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Narrow-sense heritability (h2) is an important genetic parameter that quantifies the 16 
proportion of phenotypic variance in a trait attributable to the additive genetic variation 17 
generated by all causal variants. Estimation of h2 previously relied on closely related 18 
individuals but recent developments allow the estimation of variance explained by all 19 
SNPs used in a genome-wide association study (GWAS) in conventionally unrelated 20 
individuals, i.e. the SNP-based heritability (ࢎ܁ۼ۾૛ ). In this perspective, we discuss recently 21 
developed methods to estimate ࢎ܁ۼ۾૛  for a complex trait (and genetic correlation between 22 
traits) using individual- or summary-level GWAS data. We discuss the issues that could 23 
influence the accuracy of ࢎ෡܁ۼ۾૛ , definitions, assumptions and interpretations of the models, 24 
and pitfalls of misusing the methods and misinterpreting the models and results. 25 
 26 
Estimation of the variance explained by all SNPs used in a population-based genome-wide 27 
association study (GWAS) was initially motivated by the ‘missing heritability’ problem1. The 28 
problem was that the estimated variance explained by genome-wide significant (GWS) SNPs 29 
discovered in GWAS (denoted ℎ෠ୋ୛ୗଶ ) was only a fraction of the estimated heritability (ℎ෠ଶ) from 30 
family or twin studies2, where ℎ෠ୋ୛ୗଶ  was estimated in a multi-SNP model to account for linkage 31 
disequilibrium (LD) among SNPs and in an independent sample to avoid overestimation due to 32 
the winner’s curse issue3. Taking human height as an example, ℎ෠ୋ୛ୗଶ  was 5% before 2010 (ref4), 33 
which is much smaller than a frequently quoted ℎ෠ଶ of 80% from family or twin studies5-7. This 34 
raised concerns about the cost-effectiveness of GWAS as an experimental design for gene 35 
discovery8. Several explanations of the missing heritability were proposed, including a large 36 
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number of common variants of small effect yet to be discovered, rare variants of large effects not 37 
tagged by common SNPs on genotyping arrays, and inflation in pedigree-based ℎ෠ଶ due to shared 38 
environmental effects, non-additive genetic variation, and/or epigenetic factors2,9. The missing 39 
heritability question also reignited the debate about the ‘common-disease common-variant’ 40 
hypothesis10, i.e. whether the proportion of heritability for common disease not explained by 41 
GWS loci is due to rare variants of large effect not tagged by the current generation of SNP 42 
arrays, or undetected common variants of small effect2,11. It is therefore important to quantify 43 
the proportion of variance attributable to all common SNPs (e.g. minor allele frequency, MAF ≥ 44 
0.01) used in GWAS. If common SNPs are the major contributor to heritability, then the concern 45 
about missing heritability is premature because it depends on experimental sample size of 46 
GWAS12.  47 
 48 
Estimation of the SNP-based heritability – the GREML approach 49 
SNP-based heritability (or ℎୗ୒୔ଶ ) was initially defined as the proportion of phenotypic variance 50 
explained by all SNPs on a genotyping array13, and is therefore dependent of the density of SNP 51 
array. The concept has now been expanded to refer to the variance explained by any set of SNPs, 52 
e.g. all genetic variants from in-depth whole-genome sequencing (WGS) or imputed from a 53 
reference14. Yang et al. used a mixed linear model (MLM) approach to estimate ℎୗ୒୔ଶ  in a GWAS 54 
data set of unrelated individuals, and demonstrated that common SNPs on a genotyping array 55 
explain a large proportion (45%) of variance in height13. Here, “unrelated” means distantly 56 
related individuals rather than individuals with no genetic relatedness because even random 57 
pairs of individuals drawn from a general population could share distant ancestors. Given the 58 
small ℎ෠ୋ୛ୗଶ  (5%) and relatively large ℎ෠ୗ୒୔ଶ  (45%), it was concluded that for complex traits like 59 
height there are likely a large number of common variants with effect sizes too small to pass the 60 
stringent GWS threshold (P < 5e-8) in GWAS even with the sample sizes that were considered 61 
large at that time (n = 1,000s to early 10,000s before 2010), consistent with a model of polygenic 62 
inheritance. It was subsequently predicted that more genetic variants could be discovered with 63 
larger sample sizes, whilst keeping the same experimental design of GWAS. This prediction has 64 
been realized by recent studies with n > 100,000 for height, BMI, schizophrenia and many other 65 
traits and diseases15-20. Under a polygenic model, the amount of unexplained heritability by GWS 66 
loci depends on sample size12. The aforementioned comparison of 5% vs. 80% for height in 2009 67 
(ref4) became 16% vs. 80% only five years later15. Given the nearly linear relationship between 68 
the number of GWS loci and logarithm of sample size (i.e. log(n)) observed in published GWAS12 69 
and the highly polygenic nature of most complex traits21,22, we predict that the shrinking of the 70 
gap between ℎ෠ୋ୛ୗଶ  and ℎ෠ୗ୒୔ଶ  will be less than linear in log(n) because the variance explained by 71 
SNPs discovered in studies with larger sample sizes tend to be smaller.  72 
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 73 
The Yang et al. approach was subsequently termed as Genomic Relatedness-matrix (GRM) 74 
Restricted Maximum Likelihood (GREML23) and implemented in the GCTA software tool24 (Box 75 
1). GREML shares features with a pedigree-based analysis (part 1 of the Supplementary Note), 76 
but GREML is usually applied to a sample of unrelated individuals (note that this is also the usual 77 
experimental design for GWAS), and hence ℎ෠ୗ୒୔ଶ  is unlikely to be confounded by common 78 
environmental effects (Fig. 1). For distantly related pairs, the amount of genome shared is small 79 
and highly variable, and it is unlikely that those pairs that share slightly more genome than 80 
average will also share more common environments in a relatively homogenous population. The 81 
use of unrelated individuals also means that ℎ෠ୗ୒୔ଶ  is unlikely to be contaminated with 82 
contributions from non-additive genetic effects since the shared non-additive genetic effects are 83 
tiny (of the order of the square of the shared additive effects), whereas this could be a problem 84 
in ℎ෠ଶ estimated from families depending on the study design. In addition, GREML can be applied 85 
to family data but the estimate should be interpreted with caution (part 3 of the Supplementary 86 
Note).  87 
 88 
The GREML estimate quantifies directly the proportion of phenotypic variance explained by all 89 
SNPs used in GWAS, and therefore provides the upper limit of ℎ෠ୋ୛ୗଶ  given the same 90 
experimental design. The information to estimate ℎୗ୒୔ଶ  comes from very small coefficients of 91 
genetic relationship between pairs of individuals, but small standard error (SE) of ℎ෠ୗ୒୔ଶ  (part 4 92 
of the Supplementary Note) can be achieved because of the large number of pairwise 93 
relationships (e.g., 50 million pairs for a study using 10,000 individuals) although these pairs are 94 
not independent. Subsequent work has extended the method to estimate ℎୗ୒୔ଶ  in disease data25 95 
(part 5 of the Supplementary Note) and genetic correlation (ݎ୥) between traits26,27 (part 6 of 96 
the Supplementary Note). There are several caveats of estimating ℎୗ୒୔ଶ  using data from case-97 
control studies (part 5 of the Supplementary Note) and interpreting the estimates on different 98 
scales (Fig. 2). 99 
 100 
There are multiple terms and notations that have been used to describe the parameter 101 
estimated in GREML, e.g. chip heritability, heritability on chip or SNP heritability. We 102 
recommend using the term SNP-based heritability and the notation ℎୗ୒୔ଶ . Unlike h2, which is a 103 
population-level parameter irrespective of experimental design, ℎୗ୒୔ଶ  is a parameter given a set 104 
of SNPs. We believe that it is also necessary to use a specific notation ℎ෠୮ୣୢଶ  to represent h2 105 
estimated from pedigrees (including twins) because of the potential biases in pedigree-based ℎ෠ଶ 106 
due to confounding factors such as common environmental effects. We have shown above that 107 
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ℎୗ୒୔ଶ  is per definition smaller than h2 because not all the causal variants, in particular those with 108 
low frequency, can be perfectly tagged by SNPs used in GWAS (Fig. 3a; part 1 of the 109 
Supplementary Note). Here, by causal variant we mean a genetic mutation that causes a 110 
cascade of events in biological pathways and thereby a consequence in phenotypic change, 111 
rather than an associated variant identified from GWAS. In a particular case where ℎୗ୒୔ଶ  is 112 
defined as the variance explained by all causal variants, then ℎୗ୒୔ଶ = ℎଶ. In reality, however, 113 
causal variants are unknown. An unbiased estimate of h2 might be achieved by estimating ℎୗ୒୔ଶ  114 
from in-depth WGS data assuming that all causal variants have been sequenced and there is no 115 
difference in LD between causal and other sequence variants14 (see below for more discussion).  116 
 117 
Both GWAS and estimation of ࢎ܁ۼ۾૛  by GREML utilize LD 118 
GWAS relies, by design, on genotyped common SNPs tagging unknown causal variants in the 119 
same chromosomal region. Estimating how much trait variation is tagged when fitting all SNPs 120 
simultaneously also utilise LD between SNPs and unobserved causal variants. A sparse SNP 121 
array that does not cover common variation in the genome well is less likely to lead to the 122 
discovery of trait-associated variants (even with a large sample size) and fitting those SNPs 123 
together in a GREML analysis will result in a smaller proportion of phenotypic variance 124 
explained than a denser SNP array (Fig. 3a). Since the maximum possible LD correlation 125 
between two genetic variants declines as their difference in MAF increases28, genetic variation at 126 
rare variants (i.e. MAF < 0.01) is unlikely to be well tagged by common SNPs on genotyping 127 
arrays (Fig. 3a). If causal variants are located in genomic regions with a different LD property 128 
from the rest of the genome, it can lead to bias in ℎ෠ୗ୒୔ଶ  (ref14,29,30) (see below for more 129 
discussion).  130 
 131 
Interpretation and misinterpretation of the GREML model 132 
There are several circumstances where the principle of GREML is misinterpreted and the 133 
method is misapplied, and this could potentially lead to misleading or confusing inference. 134 
GREML is based on a random-effect model (Box 1). If the number of SNPs (m) is smaller than 135 
sample size (n), this model is similar to a linear regression analysis (fixed-effect model) in terms 136 
of estimating ℎୗ୒୔ଶ  (note that the adjusted R2 from multiple regression is an unbiased estimate of 137 
variance explained in a fixed-effect model). Such a hypothetical experiment would not rely on 138 
selecting SNPs to be individually genome-wide significant nor would it rely on assumptions 139 
about the genetic architecture. In either a linear regression or random-effect model, the effect 140 
sizes of SNPs are fitted jointly (therefore accounting for LD among SNPs), i.e. the effect of any 141 
SNP is interpreted as the effect size of this SNP conditioning on the joint effects of all other SNPs. 142 
In GWAS, m is normally larger than n, in which case there is no unique solution to the fixed-effect 143 
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model, a well-known over-fitting problem in statistics. In a random-effect model, there is an 144 
additional assumption that the joint SNP effects ܝ = {ݑଵ, ݑଶ, ⋯ , ݑ௠} follow a normal distribution 145 
with mean 0 and variance ߪ୳ଶ (see Box 1 for notations) so that the model parameters are 146 
estimable even when m is larger than n, where ߪ୳ଶ is interpreted as per-SNP genetic variance 147 
when all SNPs are fitted jointly, hence accounting for LD31. Therefore, ߪ୳ଶ is not consistent across 148 
models having different numbers of SNPs. There is a misunderstanding that GREML does not 149 
account for LD because it does not have a covariance matrix for u (ref32). This is incorrect. In fact, 150 
the LD correlations among SNPs have been modeled by fitting the SNP genotype matrix W, 151 
similar to that in linear regression analysis31. Since ߪ୳ଶ is the variance of a SNP effect 152 
conditioning on the joint effects of all other SNPs and wij is the standardised SNP genotype, the 153 
additive genetic variance captured by all SNPs is ߪ୥(ୗ୒୔)ଶ = ݉ߪ୳ଶ (Box 1).  154 
 155 
In part 8 of the Supplementary Note we list five scenarios where GREML (or the GCTA tool) is 156 
misused, resulting in potentially misleading results. In addition, there is often a question about 157 
whether the SNPs included in GREML analysis need to be pruned for LD. As discussed above, 158 
GREML accounts for LD so that LD pruning is not necessary (but see later for discussion of bias 159 
due to the non-random distribution of causal variants with respect to LD). LD pruning using a 160 
high r2 threshold might increase the estimate but the likelihood of the model is not improved 161 
(Fig. 3b). We need to be cautious about interpreting the GREML estimate from pruned SNPs 162 
because of the change in MAF spectrum of SNPs by LD pruning (Fig. 3c). Changing the set of 163 
SNPs means that the underlying parameter being estimated (i.e. ℎୗ୒୔ଶ  for a set of LD- pruned 164 
SNPs) is different from the original parameter (i.e. ℎୗ୒୔ଶ  for all SNPs).  165 
 166 
Bias due to non-random distribution of causal variants with respect to LD 167 
We have mentioned above that ℎ෠ୗ୒୔ଶ  using WGS data could be a biased estimate of h2 if the LD 168 
property of causal variants is different from that of the other variants14,29,30,34. The unbiasedness 169 
of GREML to estimate h2 using WGS data depends on the ratio of ݎ୑୕ଶതതതതത (mean LD r2 between 170 
causal and non-causal variants) to ݎ୑୑ଶതതതതത (mean LD r2 between non-causal variants)14. Note that 171 
because r2 is a function of MAF, difference in MAF spectrum between causal and non-causal 172 
variants will lead to a difference in LD (i.e. MAF-mediated LD bias), resulting in a bias in ℎ෠ୗ୒୔ଶ . 173 
One solution is to stratify SNPs by MAF (i.e. MAF-stratified GREML, GREML-MS)14,33,35, which 174 
reduced bias in the estimate due to MAF-mediated LD bias. However, a more general approach is 175 
to not rely on a specific model of the interplay between allele frequency, effect size and LD, but 176 
instead stratify SNPs by MAF and LD jointly and estimating genetic variance with MAF-LD 177 
subsets. This approach, termed GREML-LDMS, appears to provide unbiased estimates of h2 as 178 
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well as the contributions of common and rare variants to h2 in simulations based on WGS data 179 
regardless of the underlying genetic architecture and distribution of causal variants with respect 180 
to MAF and LD14,36. We recommend the use of GREML-LDMS to estimate ℎୗ୒୔ଶ  in imputed data 181 
(part 9 of the Supplementary Note). The applications of GREML-LDMS to WGS data sets with 182 
rich phenotypes in the future will be able to provide nearly unbiased estimates of h2 in unrelated 183 
individuals and quantify the variance explained by all rare variants for a range of complex traits. 184 
However, large sample sizes are required to estimate ℎୗ୒୔ଶ  with useful precision because 185 
var(ℎ෠ୗ୒୔ଶ ) depends on sample size and variant density37 (part 4 of the Supplementary Note), 186 
e.g., a sample size of ~33,000 is needed to get an SE of 0.02 for WGS data. 187 
 188 
Speed et al.29 proposed a method called LDAK to correct for the LD bias. The basic idea is to 189 
weight each SNP by a factor inversely proportional to its LD with SNPs nearby. This weighting 190 
strategy can introduce MAF bias because it gives more weights to SNPs with lower MAF 191 
(supplementary figure 2 of Yang et al.14) as LD is a function of MAF28. The LDAK model implicitly 192 
assumed that variance explained by a rare variant (e.g. 0.001 < MAF < 0.01) is more than 10 193 
times larger than that by a common variant (e.g. 0.1 < MAF < 0.5) (based on the LDAK weights 194 
calculated from a sequenced reference set14). This an unrealistic model because it predicts that 195 
we would have orders of magnitude higher power to detect rare variants than common variants, 196 
a prediction not consistent with empirical results, e.g., human height15,38, schizophrenia17,39 and 197 
type 2 diabetes 40. The LDAK-induced MAF bias can be substantial especially when there is a 198 
large number of rare variants (e.g. in a WGS data set), leading to an inflated estimate of h2SNP 199 
(ref14).  200 
 201 
The LDAK model has recently been changed substantially41. Two new parameters have been 202 
added: one is a weighting according to MAF and the other is a weighting according to imputation 203 
accuracy. Although it is not the justification for these two new parameters, both give more 204 
weight to common variants than the original LDAK model41. The revised LDAK model is now 205 
more similar to GREML-LDMS14, but not identical, since Speed et al.41 estimate a higher SNP 206 
heritability from their empirical analyses on a range of traits. In simulation studies to compare 207 
the methods, the results depend on the model used to simulate the data. Unfortunately we 208 
cannot be sure which is the correct model for any given trait. GREML-LDMS makes fewer 209 
assumptions about the relationship between causal variants, LD and MAF and thereby appears 210 
to be more robust than the revised LDAK method36, although at the expense of estimating more 211 
parameters. On balance, we conclude that this topic merits further investigation36, since the 212 
relationship between local LD, locus heterozygosity and additive genetic variance for complex 213 
traits has not yet been resolved, and indeed may differ across the genome and between traits.  214 
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 215 
Assumptions about relationship between effect sizes and allele frequencies  216 
Under an evolutionarily neutral model, the proportion of variance in a polygenic trait explained 217 
by all variants in a MAF bin is linearly proportional to the width of the MAF bin14 (variance 218 
explained by a rare variant, on average, is tiny but there are a large number of them). Therefore, 219 
a significant deviation of the observed variance explained in a MAF bin from the expected value 220 
is evidence that the trait has been under natural selection14,42. In GCTA-GREML, we standardise 221 
the SNP genotypes and assume the effect size per standardised genotype (ui) follows a normal 222 
distribution. This implicitly assumes larger per-allele effect (bi) for a SNP with lower MAF, 223 
consistent with a model of purifying selection where variants with larger effect sizes tend to be 224 
under higher selection and therefore are more likely to be at lower frequencies (e.g. MAF < 0.1). 225 
There is an option in GCTA to run GREML assuming that effect size is independent of MAF 226 
(neutral model). However, the difference between the two models is trivial in GREML-MS 227 
analysis14. Moreover, GREML-MS allows the data to reveal the relationship between variance 228 
explained and MAF. One of the important extensions of GREML in the future is to estimate 229 
directly from the data a parameter to quantify the relationship between bi and allele frequency 230 
whilst fitting a mixture distribution to the joint effects of SNPs43 (part 10 of the Supplementary 231 
Note).  232 
 233 
Comparison with HE regression 234 
As described in Box 1, the GREML analysis is based on an MLM that is equivalent to fitting the 235 
additive genetic values of all individuals, i.e. ܡ = ܏ + ܍ with var(࢟) = ۯߪ୥(ୗ୒୔)ଶ + ۷ߪଶୣ. The 236 
variance components in this model are usually estimated using the REML approach. However, 237 
the REML algorithm is computationally intensive (part 11 of the Supplementary Note). 238 
Alternatively, ߪ୥(ୗ୒୔)ଶ  can be estimated from Haseman-Elston (HE) regression37,44, i.e. 239 
ݕ௜ݕ௝ = ܾ଴ + ܾଵܣ௜௝ + ݁௜௝, where ܾଵ = ߪ୥(ୗ୒୔)ଶ . The performance of GREML has been compared 240 
using extensive simulations in Golan et al.45 in ascertained case-control studies where GREML 241 
estimates can be biased especially when ݉/݊ is small and disease prevalence is low.  We also 242 
performed simulation to compare the two methods with an emphasis on the SE under a 243 
polygenic model (part 12 of the Supplementary Note). HE regression is computationally much 244 
more efficient but slightly less powerful than REML as the SE of ℎ෠ୗ୒୔ଶ  from HE regression is 245 
larger than that from REML (Supplementary Table 1 and part 12 of the Supplementary Note). 246 
The small difference in SE between the methods might not be important when the sample size 247 
becomes very large. For example, given ℎ෠ୗ୒୔ଶ  > 0.1, whether the SE is 0.01 (REML) or 0.015 (HE 248 
regression) does not make any difference in making statistical inference whether ℎୗ୒୔ଶ = 0. HE 249 
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regression can also be used to estimate multiple genetic components, e.g. multiple sets of SNPs 250 
stratified by MAF or chromosomes (Fig. 4), or to estimate genetic correlations between traits 251 
(Supplementary Table 2). These analyses have been implemented in the latest version of GCTA 252 
(GCTA-HE) (URLs). In addition, phenotype correlation – genotype correlation (PCGC) regression 253 
is an implementation of HE regression designed for disease data to attenuate the biases in 254 
ascertained case-control studies22,45 (URLs).  255 
 256 
Non-additive genetic variation 257 
The GREML approach has been extended to estimate dominance genetic variance tagged by 258 
SNPs in unrelated individuals based on a classical quantitative genetics model46. Similar to the 259 
additive GREML method, the dominance GREML model fits the additive and dominance effects of 260 
all SNPs as two sets of random effects in an MLM. This is an orthogonal model because the 261 
additive and dominance genotype variables and thereby the additive and dominance GRMs are 262 
independent. On average across 79 quantitative traits, additive genetic variation explained ~15% 263 
of the phenotypic variance and dominance genetic variation explained ~3% of variance46. The 264 
ratio of additive to dominance variance is consistent with what is expected from theory47. The 265 
method can be further extended to estimate genetic variance attributable to epistasis48 based on 266 
the classical quantitative genetics model49, ݕ = ݃஺ + ݃஽ + ݃஺஺ + ݃஺஽ + ݃஽஽ + ݁, where ݃஺ and 267 
݃஽ are the additive and dominance genetic values of an individual, and ݃஺஺, ݃஺஽ and ݃஽஽ are the 268 
additive-by-additive, additive-by-dominance, and dominance-by-dominance epistatic genetic 269 
values respectively. However, the sample size will need to be very large to get a precise estimate 270 
of epistatic variance because the variance in epistatic genetic relationship between unrelated 271 
individuals is very small. For instance, the genetic relationship for ݃஺஺ is ܣ௜௝ଶ  which has a 272 
variance of 2[var(ܣ௜௝)]ଶ (ref49). For HapMap3 SNPs, var൫ܣ௜௝൯ ≈ 2.0 × 10ିହ so that the variance 273 
in genetic relationship for ݃஺஺ is ~1.0 × 10ିଽ, meaning that we will need over a million 274 
unrelated individuals to estimate the variance explained by ݃஺஺ with an SE < 0.05 (> 4 million 275 
unrelated individuals to get SE < 0.01). The variance in dominance genetic relationship is 276 
smaller than additive genetic relationship. Therefore, it will be even more difficult to estimate 277 
variance for ݃஺஽ or ݃஽஽. 278 
 279 
Estimating ࢎ܁ۼ۾૛  and rg from GWAS summary data 280 
We have discussed above the MLM-based approaches to estimate ℎୗ୒୔ଶ  using individual-level 281 
GWAS data. There are other methods that are able to estimate ℎୗ୒୔ଶ  from GWAS summary data 282 
(estimated SNP effects and their standard errors for all SNPs analyzed in a study)50. For example, 283 
the AVENGEME method that uses maximum likelihood to estimate the genetic variance of a trait, 284 
the proportion of genetic variants affecting the trait, and the genetic covariance (and therefore 285 
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genetic correlation) between traits from the test-statistic for association between phenotype 286 
and polygenic risk score (PRS)51,52.  We can also estimate ℎୗ୒୔ଶ  directly from summary data 287 
utilizing the deviation of the observed χ2 test-statistic for a SNP from its expected value under 288 
the null hypothesis of no association56 (part 13 of the Supplementary Note). This is the basic 289 
principle of the recently developed LD score regression approach (LDSC)53. This approach 290 
requires only the summary-level data from GWAS because LD scores can be estimated from a 291 
reference sample (e.g. the 1000 Genomes). LDSC has been extended to estimate rg between traits 292 
using summary data54, which allows the traits measured on different samples regardless 293 
whether there is an overlap between samples (and the proportion of sample overlap is 294 
estimated), and to partition ℎ෠ୗ୒୔ଶ  by functional annotation55. This method provides great 295 
flexibility for researchers to estimate rg between any two GWAS data sets. Both GREML and 296 
LDSC aim at estimating the variance explained by all SNPs used in GWAS. However, there are 297 
distinct differences between the two methods. LDSC is orders of magnitude faster than GREML, 298 
and the computing time for LDSC does not scale up with sample size. LDSC only requires 299 
summary-level data, which allows the re-analysis of summary data available from published 300 
meta-analyses. There are also limitations for LDSC. LDSC is not applicable to estimate the 301 
variance explained by rare variants (e.g. MAF < 0.01) using either imputed or WGS data36 nor the 302 
variance explained by SNPs in small genomic regions (although the latter has been overcome by 303 
the HESS method developed recently56), and is more sensitive to genetic architecture of the trait 304 
(Supplementary Table 3). Result from a previous study shows that ℎ෠ୗ୒୔ଶ  from LDSC are 305 
consistently smaller than those from GREML in the same data set57, which is likely due to the 306 
errors in LD scores estimated from the reference (by default LDSC uses LD score from HapMap3 307 
SNPs in 1000 Genomes). We therefore advise using LD scores from the data used to generate the 308 
GWAS summary statistics. While this may not be possible for published summary statistics, it 309 
should be possible for large cohorts such as the UK Biobank. It is noteworthy that LDSC will 310 
suffer bias in a similar way as GREML if causal variants are non-randomly distributed with 311 
respect to LD. The estimate of ݎ୥ from bivariate LDSC is consistent with that from bivariate 312 




We have provided a perspective of the methods for estimating SNP-based heritability in 317 
unrelated individuals using GWAS data. We emphasized that the GREML approach accounts for 318 
LD when estimating ℎୗ୒୔ଶ  and actually utilizes LD to tag causal variants if they are not observed. 319 
We discussed the concepts and assumptions of the methods and scenarios under which the 320 
estimates could be biased, the methods could be misused and the results could be 321 
 10
misinterpreted. We further discussed the extensions and applications of the methods in large 322 
data sets in the future (Box 2). These future directions could expand our understanding of the 323 
genetic architecture for human complex traits and inform the design of future experiments to 324 
fully dissect genetic variation and genetic correlations. 325 
 326 
URLs 327 
GCTA: http://cnsgenomics.com/software/gcta/ 328 
GCTA-HE: http://cnsgenomics.com/software/gcta/he.html 329 
PCGC: https://www.hsph.harvard.edu/alkes-price/software/ 330 
LDSC: https://github.com/bulik/ldsc 331 
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Box 1. Statistical model used in the GREML approach to estimate ࢎ܁ۼ۾૛  477 
The statistical model used by GREML can be described in its simplest form as 478 
 ܡ = ܅ܝ + ܍  479 
where y is an ݊ × 1 vector of standardised phenotypes with n the sample size, ܅ = {ݓ௜௝} is an 480 
݊ × ݉ standardised SNP genotype matrix with m the number of SNPs, ܝ = {ݑ௜} is an ݉ × 1 481 
vector of the additive effects of all variants when fitted jointly in the model, ܝ ~ ܰ(0, ۷ߪ୳ଶ) with I 482 
an identity matrix, and e is a vector of residuals, ܍~ܰ(0, ۷ߪଶୣ). An equivalent model is 483 
 ܡ = ܏ + ܍  484 
where ܏ ~ ܰ(0, ۯߪ୥(ୗ୒୔)ଶ ) with ߪ୥(ୗ୒୔)ଶ  the additive genetic variance captured by SNPs, 485 
ߪ୥(ୗ୒୔)ଶ = ݉ߪ୳ଶ, ۯ = ܅܅ᇱ/݉, and ℎୗ୒୔ଶ  = ߪ୥(ୗ୒୔)ଶ /[ߪ୥(ୗ୒୔)ଶ + ߪଶୣ]. The parameters to be estimated 486 
are ߪ୥(ୗ୒୔)ଶ  (or ߪ୳ଶ) and ߪଶୣ. The matrix A describes the variance-covariance structure of the 487 
random effects g, and is assumed to be known in the estimation process. In practice, A is called 488 
the SNP-derived genetic (or genomic) relationship matrix (GRM) and is estimated from the SNP 489 
data. The estimate of ߪ୥(ୗ୒୔)ଶ  from GREML can be described as the estimated variance explained 490 
by all the SNPs (݉ߪො୳ଶ) or equivalently as the estimated genetic variance by contrasting the 491 





Box 2. Future applications of SNP-based heritability to large datasets 496 
The methods for estimating ℎୗ୒୔ଶ  can be extended and applied to large data sets in the future. 497 
These future directions include  498 
i) Applications of GREML-LDMS or similar approaches (that account for bias in ℎ෠ୗ୒୔ଶ  due to LD 499 
bias) to in-depth WGS data to obtain nearly unbiased estimates of h2 for a range of complex 500 
traits and quantify the variance attributable to all rare variants;  501 
ii) Methods that provide an unbiased estimate of h2 from identity-by-descent information 502 
inferred from SNP array data60;  503 
iii) Methods to estimate ℎ෠୮ୣୢଶ  from pedigree data accounting for common environmental effects 504 
and assortative mating;  505 
iv) Fast Bayesian MLM approaches based on flexible models that are applicable to WGS data to 506 
estimate the distribution of effect sizes of all variants;  507 
v) Methods to estimate ℎୗ୒୔ଶ  free of assumptions about the relationship between per-allele effect 508 




Figure Legends 512 
 513 
Figure 1. Interpretation of estimated genetic variance depends on ascertainment of the 514 
sample. Shown in red are pedigree-based heritability estimate (ℎ෠୮ୣୢଶ ) for height from 2,824 515 
pairs of full siblings in the UK Biobank (UKB) data 61 (“5k related” on the left; sibling correlation 516 
= 0.520), ℎ෠ୗ୒୔ଶ  from a GREML analysis of 35,000 unrelated UKB individuals using all the 517 
genotyped SNPs (“35k unrelated” on the right), and the estimates in between from GREML 518 
analyses in a mixed sample of unrelated and close relatives (part 2 of the Supplementary Note). 519 
The difference between ℎ෠୮ୣୢଶ  and ℎ෠ୗ୒୔ଶ  demonstrates the genetic variation (due to rare variants 520 
in particular) not tagged by genotyped SNPs and/or confounding in ℎ෠୮ୣୢଶ  from common 521 
environmental effects and non-additive genetic variation. Shown in green are the results from 522 
the same analyses as above for a simulated phenotype based on a common environmental model 523 
without genetic effect (part 2 of the Supplementary Note). Error bars indicate the standard 524 
errors of the estimates. 525 
 526 
Figure 2.  Relationship between SNP-heritability on the liability scale (ࢎࡿࡺࡼ(࢒)૛ ) and SNP-527 
heritability estimated from case-control samples. The figures show that the same estimate of 528 
ℎୗ୒୔(௟)ଶ  a) 0.1, b) 0.2, c) 0.4, d) 0.6 on the liability scale can correspond to a wide range of SNP 529 
heritability estimates from case-control samples on the observed 0-1 scale (part 5 of the 530 
Supplementary Note), depending on the proportion of cases in the sample (P) and the assumed 531 
lifetime risk of disease (K) used to transform the estimates to the liability scale. For each plotted 532 
line the minimum value assumes a population sample with P = K. In real-application we advise 533 
investigating the sensitivity of estimates of ℎௌே௉(௟)ଶ  to choice of K, but we find that the impact is 534 
small when K < 0.05. As shown in the bottom panels of the figure, for a rare disease with high 535 
ℎୗ୒୔(௟)ଶ , ℎୗ୒୔(ை)ଶ  is expected to be larger than 1 because of the non-linear relationship between 536 
genetic variance and phenotypic variance on the observed 0-1 scale. 537 
 538 
Figure 3. Estimation of genetic variance depends on ascertainment of SNPs and genetic 539 
architecture. In panel (a), shown are the estimates of ℎୗ୒୔ଶ  using SNPs on six different SNP 540 
panels for a simulated traits under two scenarios: 1) causal variants are random with both 541 
common and rare variants (red) and 2) causal variants are rare (green) (see part 7 of the 542 
Supplementary Note for details of the simulation). The six SNP panels are Affymetrix 6.0 array 543 
(affy6), Affymetrix Axiom array (affyAxiom), HapMap 3 project (HM3), Illumina OmniExpress 544 
(illu1M), Illumina Omni2.5 (illu2M) and Illumina CoreExome (illuCoreE). In panel (b), we show 545 
the effect of LD pruning on ℎ෠ୗ୒୔ଶ  and the likelihood ratio test (LRT) statistic. LD pruning was 546 
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performed based on HM3 SNPs in PLINK (--indep-pairwise 50 5 r2) with the LD r2 threshold 547 
shown on the x-axis. The last column with r2 threshold of 1 represents the result without LD 548 
pruning (i.e. all HM3 SNPs). The GREML analyses were performed using common SNPs on HM3. 549 
Shown in panel (c) is the distribution of MAF of HM3 variants after LD pruning with different r2 550 
thresholds (no pruning for r2 threshold of 1.0). 551 
 552 
Figure 4. Multiple component GREML or HE regression for sets of SNPs stratified by MAF. 553 
Results are ℎ෠ୗ୒୔ଶ  with its SE (error bar) in each MAF group averaged over 200 simulation 554 
replicates using ~11,500 unrelated individuals (SNP-based relatedness < 0.05) and ~550,000 555 
genotyped SNPs after standard quality controls. In each simulation replicate, 1,000 SNPs were 556 
selected at random as causal variants with their effects sampled from a standard normal 557 
distribution with mean 0 and variance 1. The true heritability was 0.5 (roughly 0.1 per MAF bin).  558 
The SE of the estimate from HE regression was calculated using the Jackknife approach where 559 
one individual was left out at a time.  560 




